Clinical Study

7-Day Nonbismuth-Containing Concomitant Therapy Achieves a High Eradication Rate for Helicobacter pylori in Taiwan

Table 4

Univariate analysis of the clinical factors influencing the efficacy of H. pylori eradication therapy.

Principle parameterNo. of patientsEradication rateP value

Age0.762
 <60 years22095.5%
 ≧60 years9296.7%
Sex0.010
 Female12992.2%
 Male18398.4%
Smoking0.046
  (−)24294.6%
  (+)70100%
Alcohol consumption0.610
  (−)29095.5%
  (+)22100%
Ingestion of coffee0.294
  (−)23196.5%
  (+)8193.8%
Ingestion of tea0.085
  (−)18994.2%
  (+)12398.4%
NSAID use0.503
  (−)29695.9%
  (+)1693.8%
Previous history of peptic ulcer
  (−)
  (+)
Presence of ulcer0.314
  (−)6594.9%
  (+)23495.1%
Compliance0.015
  (−)560%
  (+)30796.4%
Side effect0.082
  (−)27096.7%
  (+)4290.5%